I-ACT for Children has selected Advarra as the central IRB for the I-ACT for Children Clinical Trials Site Network – a geographically and therapeutically diverse network of pediatric trial sites committed to improving efficiencies and capabilities for the conduct of clinical trials.
I-ACT for Children launched the central IRB function to streamline processes, expedite IRB approval and improve quality during study start-up. Sites within the network, along with I-ACT for Children’s industry members, will use Advarra for consistent regulatory submissions, with the goal of faster IRB approvals and more rapid study start-up. Advarra was chosen after extensive research and discussions among our network sites and I-ACT for Children members.
Currently, 44 sites are part of the I-ACT for Children Site Network; the goal is to have 60 sites by the end of 2019 and 100 by the end of 2020.
For questions or further information, please contact Janelle Allen, Director of Research, Quality and Education, at email@example.com.